Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin
Purpose: We present a novel case of a neurotrophic keratopathy associated inflammatory hypopyon that resolved after initiation of therapy with cenegermin (Oxervate; Dompe, Milan, Italy), a recombinant human nerve growth factor (rhNGF). This finding illustrates the potential of cenegermin in advanced...
Main Authors: | Nick Zambino, Zeba A. Syed |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993621001225 |
Similar Items
-
Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis
by: Sheha H, et al.
Published: (2019-10-01) -
Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report
by: Pocobelli A, et al.
Published: (2020-11-01) -
A Case of Neurotrophic Keratopathy Associated with Nasopharyngeal Carcinoma
by: Tomoko Sato, et al.
Published: (2018-02-01) -
An unusual vertical hypopyon
by: Yan Yu Julia Chan, et al.
Published: (2020-03-01) -
Treatment of Limbal Stem Cell Deficiency in the Setting of Neurotrophic Keratopathy
by: Rozaliya HRISTOVA, et al.
Published: (2020-06-01)